Oligonucleotide Synthesis, Modification, and Purification Services Market Size, Share & Trends Analysis Report By Product (Primers, Probes, DNA Oligos, RNA Oligos, Others), By Application (Therapeutic Applications (Neurological Disorders, Rare Diseases, Other Diseases), Research Applications (PCR, Sequencing, Other Research Applications), Diagnostic Applications), Type, End-users, By Region, And By Segment Forecasts, 2025-2034
Segmentation of Oligonucleotide Synthesis, Modification, and Purification Services Market
Oligonucleotide Synthesis, Modification, and Purification Services Market- by Product
- Primers
- Probes
- DNA Oligos
- Molecular Beacons
- Randomer Oligos
- Unlocked nucleobase analog (UNA) and twisted intercalating nucleic acid (TINA) Oligos
- Others (Light-activated Oligos, Chimeric Oligos and Trimers Mixes)
- RNA Oligos
- Single Guide RNA (sgRNA)
- Small Interfering RNA (siRNA)
- MicroRNA (miRNA)
- Antisense Oligo (ASO)
- Sequencing Primers
- Aptamers
- Others (Long RNA, etc.)
- Others
Oligonucleotide Synthesis, Modification, and Purification Services Market- Application
- Therapeutic Applications
- Neurological Disorders
- Rare Diseases
- Other Diseases
- Research Applications
- PCR
- Sequencing
- Other Research Applications
- Diagnostic Applications
Oligonucleotide Synthesis, Modification, and Purification Services Market- Type
- Customized Oligos
- Predesigned Oligos
- Reagents & Consumables
- Equipment
Oligonucleotide Synthesis, Modification, and Purification Services Market- End-users
- Hospitals
- Pharmaceutical & Biotechnology Companies
- Diagnostic Laboratories
- CROs and CMOs
- Academic Research Institutes
Global Oligonucleotide Synthesis, Modification, and Purification Services Market, by Region,
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
North America Oligonucleotide Synthesis, Modification, and Purification Services Market, by Country,
- U.S.
- Canada
Europe Oligonucleotide Synthesis, Modification, and Purification Services Market, by Country,
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific Oligonucleotide Synthesis, Modification, and Purification Services Market, by Country,
- India
- China
- Japan
- South Korea
- Australia & New Zealand
Latin America Oligonucleotide Synthesis, Modification, and Purification Services Market, by Country,
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa Oligonucleotide Synthesis, Modification, and Purification Services Market, by Country,
- GCC Countries
- South Africa
- Rest of Middle East & Africa
- Company Overview
- Financial Performance
- Key Development
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Oligonucleotide Synthesis, Modification, and Purification Services Market Snapshot
Chapter 4. Global Oligonucleotide Synthesis, Modification, and Purification Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Oligonucleotide Synthesis, Modification, and Purification Services Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on OLIGONUCLEOTIDE SYNTHESIS, MODIFICATION, AND PURIFICATION SERVICES MARKET Industry Trends
Chapter 5. Oligonucleotide Synthesis, Modification, and Purification Services Market Segmentation 1: By Product, Estimates & Trend Analysis
5.1. Market Share by Product, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product:
5.2.1. Primers
5.2.2. Probes
5.2.3. DNA Oligos
5.2.3.1. Molecular Beacons
5.2.3.2. Randomer Oligos
5.2.3.3. Unlocked nucleobase analog (UNA) and twisted intercalating nucleic acid (TINA) Oligos
5.2.3.4. Others (Light-activated Oligos, Chimeric Oligos and Trimers Mixes)
5.2.4. RNA Oligos
5.2.4.1. Single Guide RNA (sgRNA)
5.2.4.2. Small Interfering RNA (siRNA)
5.2.4.3. MicroRNA (miRNA)
5.2.4.4. Antisense Oligo (ASO)
5.2.4.5. Sequencing Primers
5.2.4.6. Aptamers
5.2.4.7. Others (Long RNA, etc.)
5.2.5. Others
Chapter 6. Oligonucleotide Synthesis, Modification, and Purification Services Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Therapeutic Applications
6.2.1.1. Neurological Disorders
6.2.1.2. Rare Diseases
6.2.1.3. Other Diseases
6.2.2. Research Applications
6.2.2.1. PCR
6.2.2.2. Sequencing
6.2.2.3. Other Research Applications
6.2.3. Diagnostic Applications
Chapter 7. Oligonucleotide Synthesis, Modification, and Purification Services Market Segmentation 3: By Type, Estimates & Trend Analysis
7.1. Market Share by Type, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type:
7.2.1. Customized Oligos
7.2.2. Predesigned Oligos
7.2.3. Reagents & Consumables
7.2.4. Equipment
Chapter 8. Oligonucleotide Synthesis, Modification, and Purification Services Market Segmentation 4: By End User, Estimates & Trend Analysis
8.1. Market Share by End User, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:
8.2.1. Hospitals
8.2.2. Pharmaceutical & Biotechnology Companies
8.2.3. Diagnostic Laboratories
8.2.4. CROs and CMOs
8.2.5. Academic Research Institutes
Chapter 9. Oligonucleotide Synthesis, Modification, and Purification Services Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Oligonucleotide Synthesis, Modification, and Purification Services Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.2.3. North America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.4. North America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.2.5. North America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.3. Europe
9.3.1. Europe Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.3.3. Europe Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.4. Europe Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.3.5. Europe Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.4.3. Asia Pacific Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.4. Asia Pacific Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts By Type, 2021-2034
9.4.5. Asia Pacific Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.5. Latin America
9.5.1. Latin America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.5.3. Latin America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.4. Latin America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.5.5. Latin America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.6.3. Middle East & Africa Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.6.4. Middle East & Africa Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.6.5. Middle East & Africa Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Agilent Technologies
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service Type
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Ajinomoto Bio-Pharma Services
10.2.3. CordenPharma
10.2.4. Integrated DNA Technologies
10.2.5. Kaneka Eurogentec
10.2.6. LGC Biosearch Technologies
10.2.7. Microsynth
10.2.8. Merck KGaA
10.2.9. Nitto Avecia
10.2.10. Thermo Fisher Scientific
10.2.11. TriLink BioTechnologies
10.2.12. Creative Biolabs
10.2.13. Ella Biotech
10.2.14. Eurofins Scientific
10.2.15. Ribo Biotechnology
10.2.16. WuXi AppTec
10.2.17. GE Healthcare
10.2.18. Bio-synthesis Inc.
10.2.19. Almac Group
10.2.20. Sumitomo Chemical
10.2.21. BioSpring
10.2.22. ChemGenes
10.2.23. BianoScience GmbH
10.2.24. ATDBio Ltd
10.2.25. Burkert UK Limited
10.2.26. IBA Lifesciences GmbH
10.2.27. Other Market Players
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Ajinomoto Bio-Pharma Services, Integrated DNA Technologies, Kaneka Eurogentec, LGC Biosearch Technologies, Microsynth, MilliporeSigma, BioSpring, Cord
Oligonucleotide Synthesis, Modification, and Purification Services Market Size is valued at USD 4.69 billion in 2024 and is predicted to reach USD 12.
The Oligonucleotide Synthesis, Modification, and Purification Services Market is expected to grow at a 10.02% CAGR during the forecast period for 2025
Oligonucleotide Synthesis, Modification, and Purification Services Market is segmented into product, application, type, and end-users.
North America region is leading the Oligonucleotide Synthesis, Modification, and Purification Services Market.